Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
  • Disclosures
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form

[Disclosure] LEENO Industrial (058470) – Modification Listing (Change in Par Value) (Stock Split) / 2025-04-24

Posted on April 24, 2025August 4, 2026 By K-STOCK Editor No Comments on [Disclosure] LEENO Industrial (058470) – Modification Listing (Change in Par Value) (Stock Split) / 2025-04-24

Fact Source: Financial Supervisory Service DART

💡 3-Second Summary

LEENO Industrial has announced that the listing date for its common stock with a modified total of 76,211,850 shares, following a stock split (par value KRW 500 to KRW 100), is April 25, 2025.

📊 [Key Disclosure Details & Financial Figures]

  • Company Name: LEENO Industrial Inc.
  • Security Type & Ticker Code: Common Stock / A058470
  • Reason for Modification Listing: Stock split
  • Par Value Change: Before KRW 500 → After KRW 100
  • Total Shares Listed After Modification:
    • Common Stock: 76,211,850 shares
    • Dividend Commencement Date: January 1, 2025
  • Listing Date: April 25, 2025
  • Issuance Details: 6th Issue (Issuance Date: April 14, 2025)

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 Verification of Prior Stock Split Disclosures and KRX Official Announcements

The company has notified the modification listing date (April 25, 2025) and the post-split total number of listed shares (76,211,850 shares) resulting from the stock split (par value KRW 500 to KRW 100 per share). Specific terms and schedules regarding the stock split can be cross-checked via the prior ‘Decision on Stock Split’ filing on DART and official notices from the Korea Exchange (KRX).

📢 Disclaimer and Source Information

Source: This content was structured and regenerated based on official data submitted to the Financial Supervisory Service’s Data Analysis, Retrieval and Transfer System (DART).

Investment Risk Notice: This content is provided solely for informational and linguistic reference purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific security. All investment decisions and financial responsibilities rest entirely with the individual investor.

Contact: For compliance inquiries or copyright concerns, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Disclosures, Semiconductors

Post navigation

Previous Post: [Disclosure] LEENO Industrial (058470) – Reference Price Notice (Stock Split) / 2025-04-24
Next Post: [Disclosure] Hanwha Ocean (042660) – (Correction) Other Management Matters / 2025-04-25

Related Posts

[Disclosure] Jusung Engineering(036930) – Investor Relations (IR) Presentation / 2024-05-20 Semiconductors
[Disclosure] Jusung Engineering (036930) – Holding of Investor Relations (IR) / 2024-08-16 Disclosures
[Disclosure] LEENO Industrial (058470) – Closure of Shareholder Register or Designation of Record Date / 2023-12-12 Semiconductors
[Disclosure] Jusung Engineering (036930) – Investor Relations (IR) Presentation / 2024-05-29 Semiconductors
[Disclosure] Samsung Electronics (005930) – Decision on Disposal of Treasury Stock / 2026-07-07 Disclosures
[Disclosure] Hanwha Aerospace (012450) Corrects IR Meeting Schedule for Domestic Institutional Investors to Explain Q4 2024 Results and Outlook Disclosures

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • [Disclosure] Hanwha Ocean (042660) – Clarification on Rumors or Reports (Unconfirmed) / 2026-08-07August 7, 2026
  • [Disclosure] ALTEOGEN (196170) – Exclusive License Agreement for Recombinant Human Hyaluronidase Product ALT-B4 / 2026-08-05August 5, 2026
  • [Disclosure] ALTEOGEN (196170) – Ex-Rights (Bonus Issue) / 2026-08-04August 4, 2026
  • [Disclosure] ALTEOGEN (196170) – Market Measures on Stock Futures and Options (Bonus Issue) / 2026-08-04August 4, 2026
  • [Disclosure] Celltrion (068270) – CT-P44 (Darzalex Biosimilar) Korea Phase 3 Clinical Trial Plan Amendment Application / 2026-08-03August 3, 2026

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme